American Leprosy Missions Inc
American Leprosy Missions Inc consistently reports 0% officer compensation, demonstrating strong financial stewardship.
EIN: 135562163 · Greenville, SC · NTEE: Q123 · Updated: 2026-03-28
| Metric | Value |
|---|---|
| Total Revenue | $13.8M |
| Total Expenses | $14.5M |
| Program Spending | 85% |
| CEO/Top Officer Pay | $10 |
| Net Assets | $15.9M |
| Transparency Score | 90/100 |
Is American Leprosy Missions Inc Legit?
Appears Legitimate
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
American Leprosy Missions Inc directs 85% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About American Leprosy Missions Inc
American Leprosy Missions Inc (EIN: 135562163) is a nonprofit organization based in Greenville, SC, classified under NTEE code Q123. The organization reported total revenue of $13.8M and total assets of $16.2M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of American Leprosy Missions Inc's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
American Leprosy Missions Inc is a large nonprofit that has been operating for 71 years, with 12 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of 6.5%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $16.3M |
| Total Expenses | $14.5M |
| Surplus / Deficit | +$1.8M |
| Total Assets | $16.8M |
| Total Liabilities | $897K |
| Net Assets | $15.9M |
| Operating Margin | 10.9% |
| Debt-to-Asset Ratio | 5.3% |
| Months of Reserves | 13.9 months |
Financial Health Grade: A
In 2023, American Leprosy Missions Inc reported a surplus of $1.8M with revenue exceeding expenses, holds 13.9 months of operating reserves (strong position), has a debt-to-asset ratio of 5.3% (very low leverage).
Financial Trends
Over 12 years of filings (2011–2023), American Leprosy Missions Inc's revenue has grown at a compound annual growth rate (CAGR) of 6.5%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | +38.9% | +27.4% | +20.5% |
| 2022 | -47.6% | -51.1% | -10.6% |
| 2021 | +108.1% | +80.0% | +5.4% |
| 2020 | -20.8% | -4.5% | -11.1% |
| 2019 | -30.0% | -6.6% | +2.3% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1000 |
| IRS Ruling Date | 1955 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates American Leprosy Missions Inc with a Mission Score of 90 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 10%
- programs: 85%
- fundraising: 5%
According to IRS 990 filings, American Leprosy Missions Inc allocates its expenses as follows: admin: 10%, programs: 85%, fundraising: 5%. With 85% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $1.8M, with revenue exceeding expenses.
- Debt-to-asset ratio: 5.3%.
Executive Compensation Analysis
Executive compensation is consistently reported as 0% across all available filings, which is exceptional for an organization of its size with revenues often exceeding $10 million annually. This indicates a strong commitment to directing funds towards its mission rather than executive salaries.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Strengths
The following positive indicators were identified for American Leprosy Missions Inc:
- Consistent 0% officer compensation, indicating high program efficiency.
- Strong asset base ($16,787,849 in 202306) relative to liabilities ($896,857 in 202306).
- Stable revenue and expense trends over multiple years, demonstrating financial predictability.
- Extensive filing history (12 filings) provides good transparency and historical data for analysis.
Frequently Asked Questions about American Leprosy Missions Inc
Is American Leprosy Missions Inc a legitimate charity?
Based on AI analysis of IRS 990 filings, American Leprosy Missions Inc (EIN: 135562163) appears legitimate. Mission Score: 90/100. 0 red flags identified, 4 strengths noted.
How does American Leprosy Missions Inc spend its money?
American Leprosy Missions Inc directs 85% of its spending to programs and services. The remaining budget covers administration and fundraising costs.
Are donations to American Leprosy Missions Inc tax-deductible?
American Leprosy Missions Inc is registered as a tax-exempt nonprofit (EIN: 135562163). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
How much does the American Leprosy Missions Inc CEO make?
American Leprosy Missions Inc's highest-compensated officer earns $10 annually. The organization reported $13.8M in total revenue. Executive compensation data is disclosed in IRS 990 filings.
What percentage of American Leprosy Missions Inc's spending goes to programs?
American Leprosy Missions Inc directs 85% to programs, 5% to fundraising. This exceeds the 65% industry benchmark for efficient nonprofits.
How does American Leprosy Missions Inc compare to similar nonprofits?
With a transparency score of 90/100 (Excellent), American Leprosy Missions Inc is above average for NTEE category Q123 nonprofits. The score reflects financial transparency, program spending efficiency, and governance quality based on IRS 990 data.
Where is American Leprosy Missions Inc located?
American Leprosy Missions Inc is headquartered in Greenville, South Carolina and files with the IRS under EIN 135562163. It is classified under NTEE code Q123.
How many years of IRS 990 filings does American Leprosy Missions Inc have?
American Leprosy Missions Inc has 12 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $13.8M in total revenue.
Is American Leprosy Missions Inc a good charity?
Based on the available IRS 990 data, American Leprosy Missions Inc appears to be a very good charity. Its consistent reporting of 0% officer compensation, healthy asset-to-liability ratio, and stable financial performance over many years indicate strong financial health and a high dedication to its mission.
How has American Leprosy Missions Inc's revenue trended over time?
American Leprosy Missions Inc's revenue has generally been stable, averaging between $10 million and $16 million annually, with a notable peak of $22,364,318 in 202106. The latest reported revenue for 202306 was $16,273,016.
What is the organization's financial solvency?
The organization demonstrates strong financial solvency. In the latest filing (202306), its assets of $16,787,849 significantly outweigh its liabilities of $896,857, indicating a healthy balance sheet.
Filing History
IRS 990 filing history for American Leprosy Missions Inc showing financial trends over 12 years of public records:
Over 12 years of IRS 990 filings (2011–2023), American Leprosy Missions Inc's revenue has grown by 112.5%, moving from $7.7M to $16.3M. Total assets increased by 18.1% over the same period, from $14.2M to $16.8M. Total functional expenses rose by 97.4%, from $7.3M to $14.5M. In its most recent filing year (2023), American Leprosy Missions Inc reported a surplus of $1.8M, with revenue exceeding expenses. The organization holds $897K in liabilities against $16.8M in assets (debt-to-asset ratio: 5.3%), resulting in net assets of $15.9M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $16.3M | $14.5M | $16.8M | $897K | — | View 990 |
| 2022 | $11.7M | $11.4M | $13.9M | $546K | — | View 990 |
| 2021 | $22.4M | $23.3M | $15.6M | $479K | — | View 990 |
| 2020 | $10.7M | $12.9M | $14.8M | $856K | — | View 990 |
| 2019 | $13.6M | $13.5M | $16.6M | $498K | — | View 990 |
| 2018 | $19.4M | $14.5M | $16.2M | $306K | — | View 990 |
| 2017 | $13.0M | $14.4M | $11.4M | $785K | — | View 990 |
| 2015 | $13.1M | $14.0M | $13.5M | $598K | — | View 990 |
| 2014 | $6.7M | $7.0M | $14.9M | $873K | — | View 990 |
| 2013 | $11.3M | $11.3M | $14.9M | $657K | — | View 990 |
| 2012 | $8.1M | $9.4M | $14.0M | $819K | — | View 990 |
| 2011 | $7.7M | $7.3M | $14.2M | $897K | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $16.3M, expenses of $14.5M, and assets of $16.8M (revenue +38.9% year-over-year).
- 2022: Revenue of $11.7M, expenses of $11.4M, and assets of $13.9M (revenue -47.6% year-over-year).
- 2021: Revenue of $22.4M, expenses of $23.3M, and assets of $15.6M (revenue +108.1% year-over-year).
- 2020: Revenue of $10.7M, expenses of $12.9M, and assets of $14.8M (revenue -20.8% year-over-year).
- 2019: Revenue of $13.6M, expenses of $13.5M, and assets of $16.6M (revenue -30.0% year-over-year).
- 2018: Revenue of $19.4M, expenses of $14.5M, and assets of $16.2M (revenue +48.6% year-over-year).
- 2017: Revenue of $13.0M, expenses of $14.4M, and assets of $11.4M (revenue -0.3% year-over-year).
- 2015: Revenue of $13.1M, expenses of $14.0M, and assets of $13.5M (revenue +95.7% year-over-year).
- 2014: Revenue of $6.7M, expenses of $7.0M, and assets of $14.9M (revenue -40.6% year-over-year).
- 2013: Revenue of $11.3M, expenses of $11.3M, and assets of $14.9M (revenue +39.4% year-over-year).
- 2012: Revenue of $8.1M, expenses of $9.4M, and assets of $14.0M (revenue +5.5% year-over-year).
- 2011: Revenue of $7.7M, expenses of $7.3M, and assets of $14.2M.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for American Leprosy Missions Inc:
Data Sources and Methodology
This transparency report for American Leprosy Missions Inc is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.